Royal Bank of Canada’s TRIUS THERAPEUTICS INC COM STK (DE) TSRX Stock Holding History

Royal Bank of Canada’s Portfolio TSRX Stock Details TSRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-1,000	Closed	-$8K	–	6494
2013 Q2	$8K	Buy	+1,000	New	+$7.39K	﹤0.01%	5365

Other funds holding TSRX

PAM

Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 27.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

FCH

Freestone Capital Holdings Seattle, Washington $3.86B AUM 26.3% 1-Year Est. Return

Amici Capital New York $257M AUM 4.88% 1-Year Est. Return

FWM

Focused Wealth Management Newburgh, New York $1.15B AUM 24.81% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Royal Bank of Canada's TSRX Position: Q3 2013 in Review

Royal Bank of Canada sold out of TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) in Q3 2013, closing a stake of 1,000 shares — an estimated $8K sold.

Royal Bank of Canada first reported a position in TSRX in Q2 2013 and held it in 1 quarter. The position peaked at $8K in Q2 2013. 7 funds tracked by Wall St. Rank hold TSRX as of Q3 2013.

Royal Bank of Canada reported no remaining TRIUS THERAPEUTICS INC COM STK (DE) position as of Q3 2013 after selling out during the quarter.
Royal Bank of Canada sold 1,000 TRIUS THERAPEUTICS INC COM STK (DE) shares in Q3 2013, an estimated $8K.
Royal Bank of Canada first reported a position in TRIUS THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 1 quarter.
Royal Bank of Canada's TRIUS THERAPEUTICS INC COM STK (DE) position peaked at $8K in Q2 2013.
7 funds tracked by Wall St. Rank held TRIUS THERAPEUTICS INC COM STK (DE) as of Q3 2013.

Based on Royal Bank of Canada's 13F filing for Q3 2013, filed 14 Nov 2013.